Transcranial direct current stimulation (tDCS) has been emerging as a promising intervention to address post‐stroke upper extremity motor impairment. However, trial results have been inconsistent.

The U.S. Food and Drug Administration (FDA) granted a full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization ...

The U.S. Food and Drug Administration (FDA) granted a full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent ...

These regional blocks are safe and effective and, in our opinion, are a preferred technique for providing anesthesia for upper extremity vascular surgery. This has been supported by the work of ...

The effect of LL-BFRT on lower extremity muscle improvement has been widely discussed. However, no studies have discussed the effect of this training method on the upper extremity muscles until now ..

(Nasdaq: HUMA), a biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the U.S. Food and Drug Administration (FDA) ...